# Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®

> **NCT00652834** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 23 (actual)

## Conditions studied

- Gastrointestinal Lesions
- Signs and Symptoms, Digestive

## Interventions

- **PROCEDURE:** Small bowel capsule endoscopy (SBCE)
- **DRUG:** myfortic

## Key facts

- **NCT ID:** NCT00652834
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652834, "Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00652834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*